PV-10-based Cancer Combination Therapy Clinical Trial Design Wins Australasian Gastro-Intestinal Trials Group’s New Concepts Award
August 27, 2019 09:00 ET | Provectus Biopharmaceuticals Inc.
Two-stage, 34-patient, Phase 2 study combines PV-10 and Keytruda® (pembrolizumab) for treatment of metastatic neuroendocrine tumorsCombination powered for 19% ORR vs 3.7% ORR for Keytruda...
Nu-Med Plus Announces Investigational Study of Stored Blood as a New Path for Their NO Devices
May 10, 2016 08:00 ET | Nu-Med Plus, Inc.
SALT LAKE CITY, UT--(Marketwired - May 10, 2016) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announces they are embarking on a new investigational study applying...